SFJ Pharma Raises $45 Million

SFJ Pharmaceuticals Inc., a platform for bringing U.S. and European drugs to Japan, has raised $45 million in Series A funding, according to VentureWire. Abingworth Management and Clarus Ventures co-led the round, which was designed to help the company acquire its first products. www.sfj-pharma.com (website not currently active)

1 Comment

Leave a Reply

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget